Skip to main content
PMC home page
Infection and Immunity logoLink to Infection and Immunity
. 1975 Feb;11(2):355–359. doi: 10.1128/iai.11.2.355-359.1975

Cell-mediated immunity to Herpes simplex in humans: lymphocyte cytotoxicity measured by 51-Cr release from infected cells.

A S Russell, J S Percy, T Kovithavongs
PMCID: PMC415070  PMID: 163220

Abstract

We assessed cell-mediated immunity to herpes simplex virus type 1 antigen in patients suffering from recurrent cold sores and in a series of healthy controls. Paradoxically, all those subject to recurrent herpetic infections had, without exception, evidence of cell-mediated immunity to herpes antigens. This was demonstrated by lymphocyte transformation and specific 51Cr release from infected human amnion cells after incubation with peripheal blood mononuclear cells. Where performed, skin tests with herpes antigen were also positive. In addition, serum from these patients specifically sensitized herpesvirus-infected cells to killing by nonimmune, control mononuclear cells. These tests were negative in the control patients except in a few cases, and it is suggested that these latter may be the asymptomatic herpesvirus carriers previously recognized or that they may have experienced a genital infection.

Full text

PDF
355

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ANDERSON S. G., HAMILTON J., WILLIAMS S. An attempt to vaccinate against herpes simplex. Aust J Exp Biol Med Sci. 1950 Sep;28(5):579–584. doi: 10.1038/icb.1950.58. [DOI] [PubMed] [Google Scholar]
  2. Brunner K. T., Mauel J., Rudolf H., Chapuis B. Studies of allograft immunity in mice. I. Induction, development and in vitro assay of cellular immunity. Immunology. 1970 Apr;18(4):501–515. [PMC free article] [PubMed] [Google Scholar]
  3. Chang T. W. Recurrent viral infection (reinfection). N Engl J Med. 1971 Apr 8;284(14):765–773. doi: 10.1056/NEJM197104082841406. [DOI] [PubMed] [Google Scholar]
  4. David J. R. Lymphocyte mediators and cellular hypersensitivity. N Engl J Med. 1973 Jan 18;288(3):143–149. doi: 10.1056/NEJM197301182880311. [DOI] [PubMed] [Google Scholar]
  5. Deutsch F. H. Resistance of rabbit corneal epithelium to herpes simplex virus. N Y State J Med. 1973 Sep 1;73(17):2159–2161. [PubMed] [Google Scholar]
  6. Douglas R. G., Jr, Couch R. B. A prospective study of chronic herpes simplex virus infection and recurrent herpes labialis in humans. J Immunol. 1970 Feb;104(2):289–295. [PubMed] [Google Scholar]
  7. Ennis F. A. Host defense mechanisms against herpes simplex virus. II. Protection conferred by sensitized spleen cells. J Infect Dis. 1973 Jun;127(6):632–638. doi: 10.1093/infdis/127.6.632. [DOI] [PubMed] [Google Scholar]
  8. Forman J., Möller G. The effector cell in antibody-induced cell mediated immunity. Transplant Rev. 1973;17(0):108–149. doi: 10.1111/j.1600-065x.1973.tb00125.x. [DOI] [PubMed] [Google Scholar]
  9. Goffinet D. R., Glatstein E. J., Merigan T. C. Herpes Zoster-Varicella infections and lymphoma. Ann Intern Med. 1972 Feb;76(2):235–240. doi: 10.7326/0003-4819-76-2-235. [DOI] [PubMed] [Google Scholar]
  10. Harris R., Ukaejiofo E. O. Rapid preparation of lymphocytes for tissue-typing. Lancet. 1969 Aug 9;2(7615):327–327. doi: 10.1016/s0140-6736(69)90096-8. [DOI] [PubMed] [Google Scholar]
  11. JAWETZ E., ALLENDE M. F., COLEMAN V. R. Studies on herpes simplex virus. VI. Observations on patients with recurrent herpetic lesions injected with herpes viruses or their antigens. Am J Med Sci. 1955 May;229(5):477–485. doi: 10.1097/00000441-195505000-00002. [DOI] [PubMed] [Google Scholar]
  12. JOHNSON R. T. THE PATHOGENESIS OF HERPES VIRUS ENCEPHALITIS. II. A CELLULAR BASIS FOR THE DEVELOPMENT OF RESISTANCE WITH AGE. J Exp Med. 1964 Sep 1;120:359–374. doi: 10.1084/jem.120.3.359. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Kaufman H. E., Brown D. C., Ellison E. M. Recurrent herpes in the rabbit and man. Science. 1967 Jun 23;156(3782):1628–1629. doi: 10.1126/science.156.3782.1628. [DOI] [PubMed] [Google Scholar]
  14. Lindgren K. M., Douglas R. G., Jr, Couch R. B. Significance of Herpesvirus hominis in respiratory secretions of man. N Engl J Med. 1968 Mar 7;278(10):517–523. doi: 10.1056/NEJM196803072781001. [DOI] [PubMed] [Google Scholar]
  15. Lodmell D. L., Niwa A., Hayashi K., Notkins A. L. Prevention of cell-to-cell spread of herpes simplex virus by leukocytes. J Exp Med. 1973 Mar 1;137(3):706–720. doi: 10.1084/jem.137.3.706. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Martin M. L., Palmer E. L., Kissling R. E. Complement-fixing antigens of herpes simplex virus types 1 and 2: reactivity of capsid, envelope, and soluble antigens. Infect Immun. 1972 Feb;5(2):248–254. doi: 10.1128/iai.5.2.248-254.1972. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Merigan T. C. Host defenses against viral disease. N Engl J Med. 1974 Feb 7;290(6):323–329. doi: 10.1056/NEJM197402072900608. [DOI] [PubMed] [Google Scholar]
  18. Merigan T. C., Stevens D. A. Viral infections in man associated with acquired immunological deficiency states. Fed Proc. 1971 Nov-Dec;30(6):1858–1864. [PubMed] [Google Scholar]
  19. Nahmias A. J., Roizman B. Infection with herpes-simplex viruses 1 and 2. 3. N Engl J Med. 1973 Oct 11;289(15):781–789. doi: 10.1056/NEJM197310112891505. [DOI] [PubMed] [Google Scholar]
  20. Nii S., Morgan C., Rose H. M., Hsu K. C. Electron microscopy of herpes simplex virus. IV. Studies with ferritin-conjugated antibodies. J Virol. 1968 Oct;2(10):1172–1184. doi: 10.1128/jvi.2.10.1172-1184.1968. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Oh J. O. Enhancement of virus multiplication and interferon production by cortisone in ocular herpesvirus infection. J Immunol. 1970 Jun;104(6):1359–1363. [PubMed] [Google Scholar]
  22. Perlmann P., Perlmann H. Contactual lysis of antibody-coated chicken erythrocytes by purified lymphocytes. Cell Immunol. 1970 Sep;1(3):300–315. doi: 10.1016/0008-8749(70)90051-1. [DOI] [PubMed] [Google Scholar]
  23. Pindak F. F., Schmidt J. P., Giron D. J., Allen P. T. Interferon levels and resistance to viral infection associated with selected interferon inducers. Proc Soc Exp Biol Med. 1971 Oct;138(1):317–321. doi: 10.3181/00379727-138-35887. [DOI] [PubMed] [Google Scholar]
  24. Rasmussen L. E., Jordan G. W., Stevens D. A., Merigan T. C. Lymphocyte interferon production and transformation after Herpes simplex infections in humans. J Immunol. 1974 Feb;112(2):728–736. [PubMed] [Google Scholar]
  25. Rifkind D. The activation of varicella-zoster virus infections by immunosuppressive therapy. J Lab Clin Med. 1966 Sep;68(3):463–474. [PubMed] [Google Scholar]
  26. Russell A. S. Cell-mediated immunity to herpes simplex virus in man. J Infect Dis. 1974 Feb;129(2):142–146. doi: 10.1093/infdis/129.2.142. [DOI] [PubMed] [Google Scholar]
  27. Russell A. S. Cell-mediated immunity to herpes simplex virus in man. Am J Clin Pathol. 1973 Dec;60(6):826–830. doi: 10.1093/ajcp/60.6.826. [DOI] [PubMed] [Google Scholar]
  28. Russell A. S., Maini R. A., Bailey M., Dumonde D. C. Cell-mediated immunity to Varicella-Zoster antigen in acute Herpes zoster (shingles). Clin Exp Immunol. 1973 Jun;14(2):181–185. [PMC free article] [PubMed] [Google Scholar]
  29. Sawicki L., Chowchuvech E., Weissenbacher M., Baron S., Galin M. A. Pathogenetic studies of herpes simplex virus infection of the rabbit eye. Proc Soc Exp Biol Med. 1973 Nov;144(2):705–709. doi: 10.3181/00379727-144-37666. [DOI] [PubMed] [Google Scholar]
  30. Smith J. W., Adam E., Melnick J. L., Rawls W. E. Use of the 51 Cr release test to demonstrate patterns of antibody response in humans to herpesvirus types 1 and 2. J Immunol. 1972 Sep;109(3):554–564. [PubMed] [Google Scholar]
  31. Spencer E. S., Andersen H. K. Clinically evident, non-terminal infections with herpesviruses and the wart virus in immunosuppressed renal allograft recipients. Br Med J. 1970 Aug 1;3(5717):251–254. doi: 10.1136/bmj.3.5717.251. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Wilton J. M., Ivanyi L., Lehner T. Cell-mediated immunity in Herpesvirus hominis infections. Br Med J. 1972 Mar 18;1(5802):723–726. doi: 10.1136/bmj.1.5802.723. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Women I. P. Immunity to tissue sensitisation, HL-A and non-HL-A, as detected by the ABCIL system. Transplantation. 1974 May;17(5):453–461. doi: 10.1097/00007890-197405000-00003. [DOI] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES